Metabolic liver disease is a group of liver disorders caused by metabolic dysfunction, primarily fat accumulation in the liver. The most common type is non-alcoholic fatty liver disease (NAFLD), which affects about 25% of adults worldwide.
Metabolic liver disease develops when the liver cannot process fats properly, leading to fat buildup. Over time, this can cause inflammation, scarring (fibrosis), and even liver failure. Unlike viral hepatitis, these diseases stem from metabolic issues rather than infections.
| Type | Description | Prevalence |
|---|---|---|
| Non-alcoholic fatty liver disease (NAFLD) | Fat accumulation in the liver without alcohol abuse | 25% of adults globally |
| Non-alcoholic steatohepatitis (NASH) | NAFLD with inflammation and liver damage | 2-5% of adults globally |
| Metabolic-associated steatohepatitis (MASH) | Newer term replacing NASH, emphasizing metabolic factors | Same as NASH |
Metabolic liver disease often results from obesity, insulin resistance, and high cholesterol. Other risk factors include type 2 diabetes, metabolic syndrome, and certain medications. Unlike alcoholic liver disease, it occurs without excessive alcohol consumption.
For example, a 45-year-old patient with obesity and type 2 diabetes may develop NAFLD due to insulin resistance, leading to fat accumulation in the liver. Without intervention, this can progress to NASH, causing liver damage.
Many confuse metabolic liver disease with alcoholic liver disease, but they have different causes. While alcohol abuse damages the liver, metabolic liver disease stems from metabolic dysfunction. Another misconception is that only overweight individuals develop it, but lean individuals can also be affected.
Doctors diagnose metabolic liver disease through blood tests, imaging (ultrasound, MRI), and sometimes liver biopsies. Treatment focuses on managing underlying metabolic conditions, such as weight loss, exercise, and controlling diabetes. Medications like vitamin E and pioglitazone may help reduce liver fat and inflammation.
In my experience, patients who adopt lifestyle changes see significant improvements in liver health. A 50-year-old patient with NAFLD reduced liver fat by 30% after six months of diet and exercise, demonstrating the effectiveness of early intervention.